COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models.
Xu L, Stevens J, Hilton MB, Seaman S, Conrads TP, Veenstra TD, Logsdon D, Morris H, Swing DA, Patel NL, Kalen J, Haines DC, Zudaire E, St Croix B.
Xu L, et al. Among authors: conrads tp.
Sci Transl Med. 2014 Jun 25;6(242):242ra84. doi: 10.1126/scitranslmed.3008455.
Sci Transl Med. 2014.
PMID: 24964992
Free PMC article.